MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Cerebral metabolic network in PLA2G6-associated parkinsonism

    XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang (Shanghai, China)

    Objective: To characterize the cerebral metabolic network in PLA2G6-associated parkinsonism (PLA2G6-P). Background: PLA2G6-associated neurodegeneration is known as a continuum of phenotypes. Patients with late-onset PLA2G6-associated…
  • 2024 International Congress

    Associations between Choroid Plexus and tau in Parkinson’s Disease

    Z. Wang, J. Li, C. Cai, C. Jiang, L. Zhao (Hangzhou, China)

    Objective: To investigate the associations between the choroid plexus (ChP) and protein indicators of Parkinson’s Disease (PD). Background: The ChP is the primary organ that…
  • 2024 International Congress

    Classification of Parkinson’s disease using AI based on multi-modal brain MRI connectomics

    T. Teo, T. Welton (Singapore, Singapore)

    Objective: To develop a novel artificial intelligence (AI) model using connectivity matrices derived from multi-modal brain magnetic resonance imaging (MRI) to aid diagnosis and subtyping…
  • 2024 International Congress

    Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson’s disease

    J. Tanimura, T. Yamamoto, Y. Shigemoto, N. Sato, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To assess the predictive performance of clinical measures, including dopamine transporter (DaT) imaging, for identifying aspiration risk in patients with Parkinson’s disease (PD). Background:…
  • 2024 International Congress

    Neurovascular Involvement in Parkinson’s Disease Cognitive Impairment: A 4D Flow Study

    A. Deane, D. Myall, A. Pilbrow, R. Shoorangiz, A. Sharifzadeh-Kermani, T. Anderson, J. Dalrymple-Alford, C. Morgan, T. Melzer (Christchurch, New Zealand)

    Objective: To investigate the cerebrovascular contribution to cognitive decline in Parkinson’s disease (PD). Background: Cognitive impairment is a major non-motor feature of PD. Accruing evidence…
  • 2024 International Congress

    Associations Between Striatal Dopamine Transporter Binding and Motor Asymmetry In De Novo PD with and Without RBD

    H. Hameed, S. Elasfar, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To evaluate the associations between striatal and motor asymmetry in Parkinson’s disease with probable RBD compared to without. Background: Parkinson’s disease is typically characterized…
  • 2024 International Congress

    MIBG Uptake in the Major Salivary Glands in Patients with Parkinson’s Disease and Dementia with Lewy Bodies

    J. Ebina, S. Mizumura, H. Morioka, M. Shibukawa, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: The aim of the study was to compare the metaiodobenzylguanidine (MIBG) uptake in the major salivary glands (MSG) in patients with Parkinson’s disease (PD)…
  • 2024 International Congress

    Increased Brain-Age Gap Estimate (BrainAGE) in Neurological Wilson Disease

    A. Hausmann, J. Caspers, S. Kannenberg, S. More, K. Patil, A. Schnitzler, C. Rubbert, C. Hartmann (Duesseldorf, Germany)

    Objective: To assess grey matter (GM) volume derived brain-aging in Wilson Disease (WD) using a previously proposed machine learning (ML) algorithm. Background: GM atrophy is…
  • 2024 International Congress

    TM9SF2 Knockdown Decreases Pathological Alpha-synuclein Aggregation In Vivo

    C. Sortwell, R. Kumaran, F. Manfredsson, C. Kemp, M. Benskey, J. Patterson, A. Stoll, J. Howe, N. Kuhn, K. Luk, M. Cookson (Grand Rapids, USA)

    Objective: To determine whether knockdown of transmembrane 9 super family 2 (TM9SF2) decreases the formation of alpha-synuclein inclusions and toxicity to nigral neurons in the…
  • 2024 International Congress

    Assessment of Motor and Non-Motor Alterations Impacting Functionality in Parkinson’s Disease Patients

    R. Dias, M. Piemonte, G. Gomes, L. Bitaraes (Sao Paulo, Brazil)

    Objective: To investigate the impact of motor and non-motor changes on the functionality of individuals with Parkinson's disease Background: Parkinson's disease (PD) is the second…
  • « Previous Page
  • 1
  • …
  • 432
  • 433
  • 434
  • 435
  • 436
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley